Multi-target phosphodiesterase inhibition overcomes adipose catecholamine resistance and ameliorates systemic lipotoxicity

Tamami Fujiki, Jun Takami, Kensuke Ihara, Kohei Kawajiri, Ryosuke Ishida, Kanako Nagaoka, Yutaro Mori, Yuma Waseda, Soichiro Yoshida, Shintaro Mandai, Takayasu Mori, Koichiro Susa, Shingo Sato, Shingo Kajimura, Hiroyuki Kagechika, Tetsuo Sasano, Yasuhisa Fujii, Eisei Sohara, Shinichi Uchida, Makoto Arita, Fumiaki Ando

Open source

DOI: 10.1016/j.metabol.2026.156819
Published: 2026-11
Container: Metabolism
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.metabol.2026.156819,
  title = {Multi-target phosphodiesterase inhibition overcomes adipose catecholamine resistance and ameliorates systemic lipotoxicity},
  author = {Tamami Fujiki and Jun Takami and Kensuke Ihara and Kohei Kawajiri and Ryosuke Ishida and Kanako Nagaoka and Yutaro Mori and Yuma Waseda and Soichiro Yoshida and Shintaro Mandai and Takayasu Mori and Koichiro Susa and Shingo Sato and Shingo Kajimura and Hiroyuki Kagechika and Tetsuo Sasano and Yasuhisa Fujii and Eisei Sohara and Shinichi Uchida and Makoto Arita and Fumiaki Ando},
  year = {2026},
  journal = {Metabolism},
  doi = {10.1016/j.metabol.2026.156819},
  url = {https://doi.org/10.1016/j.metabol.2026.156819}
}

RIS

TY  - JOUR
TI  - Multi-target phosphodiesterase inhibition overcomes adipose catecholamine resistance and ameliorates systemic lipotoxicity
AU  - Tamami Fujiki
AU  - Jun Takami
AU  - Kensuke Ihara
AU  - Kohei Kawajiri
AU  - Ryosuke Ishida
AU  - Kanako Nagaoka
AU  - Yutaro Mori
AU  - Yuma Waseda
AU  - Soichiro Yoshida
AU  - Shintaro Mandai
AU  - Takayasu Mori
AU  - Koichiro Susa
AU  - Shingo Sato
AU  - Shingo Kajimura
AU  - Hiroyuki Kagechika
AU  - Tetsuo Sasano
AU  - Yasuhisa Fujii
AU  - Eisei Sohara
AU  - Shinichi Uchida
AU  - Makoto Arita
AU  - Fumiaki Ando
PY  - 2026
JO  - Metabolism
DO  - 10.1016/j.metabol.2026.156819
UR  - https://doi.org/10.1016/j.metabol.2026.156819
ER  -

APA

Fujiki, T., Takami, J., Ihara, K., Kawajiri, K., Ishida, R., Nagaoka, K., Mori, Y., Waseda, Y., Yoshida, S., Mandai, S., Mori, T., Susa, K., Sato, S., Kajimura, S., Kagechika, H., Sasano, T., Fujii, Y., Sohara, E., Uchida, S., Arita, M., & Ando, F. (2026). Multi-target phosphodiesterase inhibition overcomes adipose catecholamine resistance and ameliorates systemic lipotoxicity. Metabolism. https://doi.org/10.1016/j.metabol.2026.156819

Source records

crossref · retrieved 2026-11-04T20:52:58.395Z